Kotak Alts invests INR 200 Million in Cellogen Therapeutics EP News Bureau May 18, 2026 Kotak Alternate Asset Managers Limited (Kotak Alts), through its Kotak Life Sciences Fund I (KLSF-I), which invests in early- to…
